E5: (Pt2) Vidya Vasu-Devan - Gates Strategic Investment Fund. How does early stage biotech affect the majority world? What is the impact of volume guarantees?

Frontier Market Investing

English - March 15, 2019 05:00 - 20 minutes - 9.55 MB - ★★★★★ - 19 ratings
Investing Business News Business News invest investing emerging markets entrepreneurship private equity venture capital dfi Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: E4: (Pt1) Vidya Vasu-Devan - Gates Strategic Investment Fund. Why have a VC fund at the Gates Foundation? What can be learned from M-KOPA?

Next Episode: E6 How do you raise 100M in frontier markets? Gustaf Agartson & the BIMA founder's story

In the second part of a two-part interview, Vidya dives into the Bill & Melinda Gates Strategic Investment Fund (SIF) strategy investing in early-stage biotech companies as well as volume guarantees.

Host: Hunter Sims
Producer: Allison Sims
Music: "Nowhere Land" Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0 License